Can-C™ eye-drops are the original™ brand- developed by Innovative Vision Products (IVP). This group were the first to research, publish and prove how eye-drops can reduce and even eradicate cataract. Accordingly there are active US and EU patents (and others pending) on this unique and special product.
Can-C™ eye-drops are the formula from the original published human trials. They contain a purified and racemized form of n-acetylcarnosine (made in Japan); this natural dipeptide has potent anti-glycating and anti-oxidant properties that prevents lipid peroxidation. Note that the formula is important- it's not all about the n-acetylcarnosine; the specific carrier agents and their purity are also important. If you look at the Can-C™ formula you will see differences to the copycats, (remember it is only Can-C™ that is patented in recognition of the original work). If you want the best possible results in the fastest possible time, then choose Can-CT"' to deliver them according to the clinical trials.
Patients placed two-drops of Can-C™ into their eyes twice daily for a 6-month period, the outcome was:
-90% saw an improvement in their visual acuity.
-88.9% of patients showed improvement in the clarity of their lens.
There have been numerous reports of cataract shrinkage and even disappearance with documented evidence that Can-C™ eye-drops remain effective (and safe) more than 24-months later. The most commonly expressed initial reports are that glare is significantly improved, (for example night driving is much safer) and color perception is enhanced.
More evidence is mounting that Can-C™ is efficacious for many conditions including:
- Cataracts (particularly the senile version)
- Corneal disorders
- Eye strain
- Ocular inflammation
- Blurred vision
- Vitreous opacities and lesions
- Diabetes mellitus complications
- Contact lens users- Dry eye syndrome
Of special interest may be to persons who wear contact lenses. This is because Can-C™ inhibits the accumulation of lactic acid and therefore contacts can be worn for longer periods without pain.
We have also received reports that Can-C™ not only aids dry-eye syndrome with its lubricants, but that Can-C™ helps to unclog proteins from the lacrimal ducts, thus releasing more natural tears onto the eye.
In a similar way, it is also believed that the unclogging of proteins in the eye's drain, (the Schlemm valve), helps to reduce intraocular pressure and thus aids glaucoma.